Verification with the utility of an established rapid assessment of brain safety for newly developed vaccines|RISS 상세보기

다국어 초록 (Multilingual Abstract)

In the twenty-first century, high contagious infectious diseases such as SARS (Severe Acute Respiratory Syndrome), MERS (Middle East Respiratory Syndrome), FMD (Foot-and-Mouth Disease) and AI (Avian Influenza) have become very prevalent, causing treat harm to humans and animals in aspect of public health, and economical issues. The critical problem is that newly-reported infectious diseases that humans firstly experience are expected to continue to emerge, and these diseases will be spreading out rapidly. Therefore, rapid and safe supplies of effective vaccines are most pivotal to prevent the rapid prevalent of new infection, but international standards or assessing protocol the safety of urgent vaccines are not established well. In our previous study, since we established a module to assess the brain safety of urgent vaccines, therefore, it is necessary to verify that this established module for assessing brain safety could work effectively in commercially available two vaccines (one killed- and on live-vaccines). We compared the results of Evans blue (EB) assay and qPCR analysis by injection of two kinds of vaccines, PBS and Lipopolysaccharide (LPS) under the condition of the module previously reported. We confirmed that the brain safety test module for urgent vaccine we established is very reproducible. Therefore, it is believed that this vaccine safety testing method can be used to validate brain safety when prompt supply of a newly developed vaccines is needed.

번역하기

참고문헌 (Reference)

1 Tomohiro Kondo, "Transient forebrain ischemia induces impairment in cognitive performance prior to extensive neuronal cell death in Mongolian gerbil (Meriones unguiculatus)" 대한수의학회 19 (19): 505-511, 2018

2 이순신, "Time-dependent changes of calbindin D-28K and parvalbumin immunoreactivity in the hippocampus of rats with streptozotocin-induced type 1 diabetes" 대한수의학회 14 (14): 373-380, 2013

3 Cereijido M, "Tight junction and polarity interaction in the transporting epithelial phenotype" 1778 (1778): 770-793, 2008

4 Fanning AS, "The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton" 273 (273): 29745-29753, 1998

5 Edelblum KL, "The tight junction in inflammatory disease : communication breakdown" 9 (9): 715-720, 2009

6 Elia L, "The knockout of miR-143 and-145 alters smooth muscle cell maintenance and vascular homeostasis in mice : correlates with human disease" 16 (16): 1590-1598, 2009

7 Ballabh P, "The blood-brain barrier : an overview : structure, regulation, and clinical implications" 16 (16): 1-13, 2004

8 Cummins PM, "Occludin : one protein, many forms" 32 (32): 242-250, 2012

9 Waterson MJ, "Neuronal regulation of energy homeostasis : beyond the hypothalamus and feeding" 22 (22): 962-970, 2015

10 Jin Hee Kim, "Neonatal influenza virus infection affects myelination in influenza-recovered mouse brain" 대한수의학회 19 (19): 750-758, 2018